European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Grant programme · United States

Drug Use and Addiction Research Programs

Drug Use and Addiction Research Programs (United States): the programme's calls and grants. 162 calls on the site, 17 open now; its calls usually open in September. Data as of 17 November 2026; updated daily.

Funder: National Institutes of Health (Department of Health and Human Services)

Grants in the last 24 months
0
Recipients
0
Open calls
17
Calls on the site
162

Calls usually open in September

About the programme

Objectives: To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS.…

Read more at the source

Open calls

Grant callStatusCloses
Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)Open8 February 2027
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) (round Aug 2024 – Feb 2027)Open11 February 2027
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)Open5 March 2027
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) (round Aug 2024 – Mar 2027)Open6 March 2027
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) (round Dec 2024 – Aug 2027)Open11 August 2027
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)Open27 October 2027
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) (round Aug 2026 – Jun 2028)Open16 June 2028
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)Open21 August 2028
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)Open25 September 2028
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)Open5 November 2028
Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)Open16 March 2029
Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)Open16 July 2029
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2Forthcoming—
NIDA Avenir Program: Fundamental Mechanistic Research in Addiction ScienceForthcoming—
Intervention Research to Improve Native American HealthForthcoming—
NIDA Core "Center of Transformative Science" Grant ProgramForthcoming—
NIH Blueprint Initiative: Tools for Germline Gene Editing in the Nervous SystemForthcoming—

Earlier calls

Grant callStatusCloses
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)Closed13 November 2026
Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)Closed27 October 2026
Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed)Closed1 October 2026
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)Closed30 September 2026
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) (round Jan 2025 – Sep 2026)Closed7 September 2026
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)Closed5 September 2026
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) (round Nov 2024 – Aug 2026)Closed13 August 2026
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) (round Sep 2024 – Jul 2026)Closed29 July 2026
D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) (round Dec 2024 – Jul 2026)Closed29 July 2026
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) (round Nov 2024 – Jul 2026)Closed6 July 2026
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed) (round Aug 2024 – Mar 2026)Closed19 March 2026
Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)Closed11 March 2026
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)Closed10 March 2026

Grant calendars

Grants for projects that started between 17 November 2024 and 17 November 2026; amounts in euro at the Eurostat rate of each year.

Questions and answers

When does Drug Use and Addiction Research Programs open calls?
17 open now: Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory… (8 February 2027), NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) (11 February 2027), High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) (5 March 2027), …. Its calls usually open in September.